David Bennett has been appointed as IP Australia’s first intellectual property (IP) Counsellor to China, where he will work out of the Australian Embassy in Beijing from early 2017. David’s role will involve supporting Australian businesses to navigate the Chinese IP systems. This will include providing guidance on IP registration, enforcement procedures and the court system; developing educational resources; and liaising with the Australian business community in China. He will also engage with the Chinese Government to address common issues and concerns around IP policy.
David has always had a strong interest in innovation and excelled in this area. With the exception of a nine-month position as the Director of Intellectual Property at Haplomics, an early-stage biomedical start-up focused on haemophilia treatment and gene therapy, David has worked at IP Australia since 2011. As David’s background is in molecular biology, he first joined IP Australia as a biotechnology patent examiner, but is now in the policy space. This combination of experience gives him a strong technical and policy background in IP.
David has received a high level of education throughout his academic career. He achieved a Bachelor of Philosophy from the Australian National University (ANU), with first class honours in biochemistry and molecular biology. He also studied as an exchange student at the University of California, San Diego during his degree at ANU. David furthered his studies at Osaka University in Japan, where he obtained a Masters of Pharmaceutical Sciences, with his thesis covering viral vectors for gene therapy applications. He was awarded the Japanese Government (Monbukagakusho) Scholarship. David is fluent in Japanese, and currently learning Mandarin for his Chinese posting.